These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

538 related items for PubMed ID: 21205837

  • 1. CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway.
    Yu T, Wu Y, Helman JI, Wen Y, Wang C, Li L.
    Mol Cancer Res; 2011 Feb; 9(2):161-72. PubMed ID: 21205837
    [Abstract] [Full Text] [Related]

  • 2. CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway.
    Tan CT, Chu CY, Lu YC, Chang CC, Lin BR, Wu HH, Liu HL, Cha ST, Prakash E, Ko JY, Kuo ML.
    Carcinogenesis; 2008 Aug; 29(8):1519-27. PubMed ID: 18487224
    [Abstract] [Full Text] [Related]

  • 3. Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis.
    Tang CH, Tan TW, Fu WM, Yang RS.
    Carcinogenesis; 2008 Jan; 29(1):35-43. PubMed ID: 17916907
    [Abstract] [Full Text] [Related]

  • 4. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin.
    Zuo JH, Zhu W, Li MY, Li XH, Yi H, Zeng GQ, Wan XX, He QY, Li JH, Qu JQ, Chen Y, Xiao ZQ.
    J Cell Biochem; 2011 Sep; 112(9):2508-17. PubMed ID: 21557297
    [Abstract] [Full Text] [Related]

  • 5. LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.
    Wu M, Chen Q, Li D, Li X, Li X, Huang C, Tang Y, Zhou Y, Wang D, Tang K, Cao L, Shen S, Li G.
    J Cell Biochem; 2008 Jan 01; 103(1):245-55. PubMed ID: 17549698
    [Abstract] [Full Text] [Related]

  • 6. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
    Impola U, Uitto VJ, Hietanen J, Hakkinen L, Zhang L, Larjava H, Isaka K, Saarialho-Kere U.
    J Pathol; 2004 Jan 01; 202(1):14-22. PubMed ID: 14694517
    [Abstract] [Full Text] [Related]

  • 7. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
    Chinni SR, Sivalogan S, Dong Z, Filho JC, Deng X, Bonfil RD, Cher ML.
    Prostate; 2006 Jan 01; 66(1):32-48. PubMed ID: 16114056
    [Abstract] [Full Text] [Related]

  • 8. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
    O-charoenrat P, Modjtahedi H, Rhys-Evans P, Court WJ, Box GM, Eccles SA.
    Cancer Res; 2000 Feb 15; 60(4):1121-8. PubMed ID: 10706134
    [Abstract] [Full Text] [Related]

  • 9. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
    Park SK, Hwang YS, Park KK, Park HJ, Seo JY, Chung WY.
    Carcinogenesis; 2009 Jul 15; 30(7):1225-33. PubMed ID: 19420016
    [Abstract] [Full Text] [Related]

  • 10. Stromal cell-derived factor-1/CXCR4 enhanced motility of human osteosarcoma cells involves MEK1/2, ERK and NF-kappaB-dependent pathways.
    Huang CY, Lee CY, Chen MY, Yang WH, Chen YH, Chang CH, Hsu HC, Fong YC, Tang CH.
    J Cell Physiol; 2009 Oct 15; 221(1):204-12. PubMed ID: 19496172
    [Abstract] [Full Text] [Related]

  • 11. Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9.
    Dong QZ, Wang Y, Tang ZP, Fu L, Li QC, Wang ED, Wang EH.
    Am J Pathol; 2013 Mar 15; 182(3):954-64. PubMed ID: 23306155
    [Abstract] [Full Text] [Related]

  • 12. Gypenosides inhibits migration and invasion of human oral cancer SAS cells through the inhibition of matrix metalloproteinase-2 -9 and urokinase-plasminogen by ERK1/2 and NF-kappa B signaling pathways.
    Lu KW, Chen JC, Lai TY, Yang JS, Weng SW, Ma YS, Lu PJ, Weng JR, Chueh FS, Wood WG, Chung JG.
    Hum Exp Toxicol; 2011 May 15; 30(5):406-15. PubMed ID: 20511288
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials.
    Erdem NF, Carlson ER, Gerard DA, Ichiki AT.
    J Oral Maxillofac Surg; 2007 Sep 15; 65(9):1725-33. PubMed ID: 17719389
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma.
    Katayama A, Ogino T, Bandoh N, Nonaka S, Harabuchi Y.
    Clin Cancer Res; 2005 Apr 15; 11(8):2937-46. PubMed ID: 15837745
    [Abstract] [Full Text] [Related]

  • 20. CADPE inhibits PMA-stimulated gastric carcinoma cell invasion and matrix metalloproteinase-9 expression by FAK/MEK/ERK-mediated AP-1 activation.
    Han H, Du B, Pan X, Liu J, Zhao Q, Lian X, Qian M, Liu M.
    Mol Cancer Res; 2010 Nov 15; 8(11):1477-88. PubMed ID: 21047770
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.